'Phenomenal' REDUCE-IT establishes triglyceride theory

 

CHICAGO - REDUCE-IT is a phenomenal trial and a game changer because it has shown for the first time that triglyceride reduction with an appropriate therapy - in this case icosapent ethyl - when used in appropriate doses can make a significant difference. That's according to Prakash C. Deedwania, MD, chief of the cardiology division at the Veterans Affairs Medical Center/University of California San Francisco Program in Fresno, who joined MDedge reporter Richard Mark Kirkner for a video interview at the American Heart Association scientific sessions. For more details on REDUCE-IT, visit www.mdedge.com.